Edition:
United Kingdom

Novozymes A/S (NZYMb.CO)

NZYMb.CO on Copenhagen Stock Exchange

309.20DKK
3:32pm GMT
Change (% chg)

kr.2.60 (+0.85%)
Prev Close
kr.306.60
Open
kr.307.00
Day's High
kr.309.80
Day's Low
kr.299.60
Volume
314,253
Avg. Vol
453,201
52-wk High
kr.363.10
52-wk Low
kr.288.70

Latest Key Developments (Source: Significant Developments)

Novozymes CFO Says Weaker Middle East Growth Is Expected To Continue
Wednesday, 24 Oct 2018 

Oct 24 (Reuters) - NOVOZYMES' CFO PRISCA HAVRANEK-KOSICEK TOLD REUTERS::NOVOZYMES CFO SAYS REASON FOR SALES GROWTH EXPECTED AT LOWER END OF RANGE IS LOWER GROWTH IN THE MIDDLE EAST.NOVOZYMES CFO SAYS LOWER MIDDLE EAST GROWTH IS EXPECTED TO CONTINUE IN THE FOURTH QUARTER.NOVOZYMES CFO SAYS HAD HOPED FOR HIGHER GROWTH IN HOUSEHOLD CARE SO FAR THIS YEAR.NOVOZYMES MAINTAINED ITS ORGANIC SALES GROWTH GUIDANCE OF 4-6 PCT FOR THIS YEAR BUT SAID IT WOULD LIKELY CLOSE THE YEAR TOWARD THE LOWER PART OF THE RANGE nASP0001N0.  Full Article

Novozymes: Q3 net profit at DKK 807 mln
Wednesday, 24 Oct 2018 

Oct 24 (Reuters) - Novozymes A/S ::REG-INTERIM REPORT FOR THE FIRST NINE MONTHS OF 2018.5% ORGANIC SALES GROWTH IN Q3.FULL-YEAR 2018 OUTLOOK: ORGANIC SALES GROWTH OF 4-6% MAINTAINED.Q3 NET PROFIT DKK 807 MILLION (REUTERS POLL DKK 814 MILLION).Q3 EBIT DKK 1.04 BILLION (REUTERS POLL DKK 1.04 BILLION).MAINTAIN ORGANIC REVENUE GROWTH GUIDANCE, WITH THE LIKELIHOOD THAT WILL CLOSE THE YEAR TOWARD THE LOWER PART OF THE RANGE.FULL-YEAR 2018 OUTLOOK: NET PROFIT GROWTH OUTLOOK INCREASED TO 1-3%.Q3 SALES DKK 3.66 BILLION (REUTERS POLL DKK 3.68 BILLION).NET PROFIT GROWTH OUTLOOK INCREASED TO 1-3% ( ABOUT0%)..  Full Article

BioAg Alliance Announces Updated Research And Development Pipeline
Thursday, 4 Jan 2018 

Jan 4 (Reuters) - BioAg Alliance::BIOAG ALLIANCE - ANNOUNCED UPDATED RESEARCH AND DEVELOPMENT PIPELINE.BIOAG ALLIANCE - SEES ACCELERON B-300 SAT TO BE APPLIED TO BETWEEN 8-10 MILLION ACRES IN 2018, WHILE ACCELERON B-360 ST SCHEDULED TO ENTER MARKET IN 2019.BIOAG ALLIANCE - IN 2019-2020, PLAN TO LAUNCH PRODUCTS FOR GROWERS OF CORN, OILSEED RAPE AND WHEAT IN EUROPE.  Full Article

Novozymes Appoints Prisca Havranek-Kosicek New CFO
Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - NOVOZYMES ::PRISCA HAVRANEK-KOSICEK NEW CFO.  Full Article

Novozymes CEO Sells 50,000 Of Own Shares
Wednesday, 29 Nov 2017 

Nov 29 (Reuters) - Novozymes ::CEO SELLS 50.000 OF OWN SHARES IN COMPANY FOR A TOTAL VALUE OF DKK 17.2 MILLION.  Full Article

Novozymes completes share buyback program
Friday, 10 Nov 2017 

Nov 10 (Reuters) - NOVOZYMES ::‍NOVOZYMES HAS NOW COMPLETED ANNOUNCED SHARE BUYBACK PROGRAM OF B SHARES WORTH UP TO DKK 2 BILLION IN TOTAL DURING 2017​.  Full Article

Novozymes Q3 EBIT above expectations at DKK 1.06 bln
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - NOVOZYMES ::‍FULL-YEAR OUTLOOK ADJUSTED​.‍NOW EXPECTS ORGANIC REVENUE GROWTH 3-5% (2-5%)​.NOVOZYMES - STILL SOME UNCERTAINTY REGARDING AGRICULTURE-RELATED MARKETS IN Q4‍​.NOW EXPECTS ‍DKK REVENUE GROWTH 2-4% (1-4%)​.NOW EXPECTS ‍EBIT GROWTH 2-4% (1-4%)​.Q3 SALES DKK ‍​3.58 BILLION (REUTERS POLL DKK 3.54 BILLION).Q3 EBIT DKK ‍​1.06 BILLION (REUTERS POLL DKK 1.01 BILLION).Q3 NET PROFIT 819 MILLION (REUTERS POLL DKK 789 MILLION).  Full Article

Novozymes launches two ethanol enzyme products in Europe
Thursday, 17 Aug 2017 

Aug 17 (Reuters) - DANISH ENZYMES PRODUCER NOVOZYMES ANNOUNCES:LAUNCH OF SPIRIZYME 2.0 T AND SPIRIZYME ULTRA T FOR EUROPEAN ETHANOL MARKET.  Full Article

Shares in enzymes maker Novozymes tumble as Middle East sales drag

COPENHAGEN Shares in enzymes maker Novozymes fell more than 7 percent on Wednesday after the Danish company said full-year sales were likely to be at the low end of its forecast range due to weakness in Middle East markets.